Delivery Order SPE2DB22D2206-SPE2DB25FFV86

Award Date 2/26/25
Potential Completion Date 3/19/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $17,777.00 firm fixed price contract is for ENHERTU 100 MG VIALS, a medication, with a period of performance through February 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $91,844.40, is for the supply of ENHERTU 100 MG VIALS, a specialty pharmaceutical product. The contract has a completion date of August 11, 2022 and is a firm fixed-price contract. The contract is not designated as a set-aside. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENHERTU 100 MG VIALS, a pharmaceutical product, with a ceiling value of $17,777.00. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) running from January 2025 to February 2025. The place of performance is Conshohocken, Pennsylvania. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG vials. The contract has a ceiling value of $16,832.70 and runs through December 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,416.30 firm fixed price contract is for the supply of ENHERTU 100 MG vials, a specialty oncology medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG vials. The delivery order, valued at $19,341.24, is a firm-fixed-price contract with an ultimate completion date of October 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,221.60 firm fixed price contract is for the delivery of ENHERTU 100 MG vials, a specialty pharmaceutical product. The contract has a March 12, 2025 completion date and was awarded on February 19, 2025. This contract is associated with a larger $999,999,999 Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $19,341.24 firm fixed-price contract is for the supply of ENHERTU 100 MG VIALS, a pharmaceutical product. The delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The $3,223.56 contract is for the delivery of ENHERTU 100 MG VIALS, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENHERTU 100 MG vials. The contract has a ceiling value of $16,270.30 and is set to expire on December 6, 2024. It is a firm-fixed-price contract, with no set-aside requirements indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFV86
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,777.00, is for the supply of ENHERTU 100 MG VIALS, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a firm fixed price pricing type and a performance period through March 19, 2025. The contract does not have a set-aside designation, indicating open competition.

Generated 5/28/25, 11:03 AM